Table 1 Patient demographic and treatment characteristics; percentiles are listed parenthetically.
Characteristic | Series | Primary disease | Recurrent disease | ||
|---|---|---|---|---|---|
(n = 42) | (n = 33) | (n = 9) | |||
Age (yrs) | |||||
Median | 60 | 63 | 46 | ||
Range | 20–86 | 40–86 | 20–59 | ||
Sex | |||||
Male | 27 (64) | 20 (60) | 7 (78) | ||
Female | 15 (36) | 13 (40) | 2 (22) | ||
Surgery | |||||
Biopsy alone/unresectable | 8 (19) | 6 (19) | 2 (22) | ||
Debulking/resection | 34 (81) | 27 (81) | 7 (78) | ||
Complete resection | 13(31) | 10 (30) | 3 (33) | ||
Partial resection | 21(50) | 17 (51) | 4 (44) | ||
Chemotherapy | None | 19 (45) | 17 (51) | 2 (22) | |
Any agent | 23 (55) | 16 (49) | 7 (78) | ||
Carmustine (iv) | 5 (12) | 2 (6) | 3 (33) | ||
Carmustine (wafer) | 2 (5) | 1 (3) | 1 (11) | ||
Lomustine | 1 (2) | 1 (3) | - | ||
Irinotecan | 3(7) | 2 (6) | 1 (11) | ||
Penicillamine | 3 (7) | 3 (9) | - | ||
Temozolomide | 9(21) | 7 (21) | 2 (22) | ||
IMRT technique | |||||
IMRT Only | 30 (72) | 22 (66) | 8 (89) | ||
3DCRT + IMRT boost | 12 (28) | 11 (33) | 1 (11) |